Clinical Trial Update: Lamprene Multiple Patient Program

View source ↗

Summary

A clinical trial update for a Lamprene (clofazimine) multiple patient program sponsored by Novartis Pharmaceuticals for non-tuberculous mycobacterial infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-tuberculous Mycobacterial Infections

Drugs mentioned

• Lamprene (clofazimine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-Tuberculous Mycobacterial (NTM) Infections | Status: AVAILABLE